Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Short term Debt (2020 - 2022)

Akso Health (AHG) has disclosed Short term Debt for 3 consecutive years, with $37.2 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Short term Debt rose 1153.04% year-over-year to $37.2 million, compared with a TTM value of $37.2 million through Mar 2022, up 1153.04%, and an annual FY2022 reading of $37.2 million, up 1153.04% over the prior year.
  • Short term Debt was $37.2 million for Q1 2022 at Akso Health, up from $3.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $37.2 million in Q1 2022 and bottomed at $2.1 million in Q1 2020.
  • Average Short term Debt over 3 years is $14.1 million, with a median of $3.0 million recorded in 2021.
  • The sharpest move saw Short term Debt skyrocketed 41.8% in 2021, then surged 1153.04% in 2022.
  • Year by year, Short term Debt stood at $2.1 million in 2020, then surged by 41.8% to $3.0 million in 2021, then soared by 1153.04% to $37.2 million in 2022.
  • Business Quant data shows Short term Debt for AHG at $37.2 million in Q1 2022, $3.0 million in Q1 2021, and $2.1 million in Q1 2020.